REQUEST A DEMO
Total
USD $0.00
Search more companies

Astrazeneca Pharmaceuticals (Phils.) Inc. (Philippines)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Astrazeneca Pharmaceuticals (Phils.) Inc. Profile Updated: March 11, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Astrazeneca Pharmaceuticals (Phils.) Inc. is an enterprise located in Philippines, with the main office in Taguig. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. It was incorporated on September 13, 1999. In its most recent financial highlights, the company reported a net sales revenue increase of 26.09% in 2024. Its total assets grew by 25.85% over the same period. In 2024, Astrazeneca Pharmaceuticals (Phils.) Inc.’s net profit margin increased by 5.14%.

Headquarters
16Th Floor, Inoza Tower, 40Th Street, Bonifacio Global City
Taguig; National Capital Region;

Contact Details: Purchase the Astrazeneca Pharmaceuticals (Phils.) Inc. report to view the information.

Basic Information
Financial Auditors:
Purchase the Astrazeneca Pharmaceuticals (Phils.) Inc. report to view the information.
Incorporation Date:
September 13, 1999
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Astrazeneca Pharmaceuticals (Phils.) Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
26.09%
Total Operating Revenue
26.09%
Operating Profit
31.53%
EBITDA
51.24%
Net Profit/Loss for the Period
1315.51%
Total Assets
25.85%
Total Equity
5.58%
Operating Profit Margin
3.22%
Net Profit Margin
5.14%
Return on Equity (ROE)
24.22%
Debt / Equity
21.87%
Quick Ratio
-0.12%
Cash Ratio
-0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?